Transcriptional_JJ
activity_NN
of_IN
core_NN
binding_NN
factor-alpha_NN
-LRB-_-LRB-
AML1_NN
-RRB-_-RRB-
and_CC
beta_NN
subunits_NNS
on_IN
murine_JJ
leukemia_NN
virus_NN
enhancer_NN
cores_NNS
._.

Core_NN
binding_NN
factor_NN
-LRB-_-LRB-
CBF_NN
-RRB-_-RRB-
,_,
also_RB
known_VBN
as_IN
polyomavirus_NN
enhancer-binding_JJ
protein_NN
2_CD
and_CC
SL3_NN
enhancer_NN
factor_NN
1_CD
,_,
is_VBZ
a_DT
mammalian_JJ
transcription_NN
factor_NN
that_WDT
binds_VBZ
to_TO
an_DT
element_NN
termed_VBN
the_DT
core_NN
within_IN
the_DT
enhancers_NNS
of_IN
the_DT
murine_JJ
leukemia_NN
virus_NN
family_NN
of_IN
retroviruses_NNS
._.

The_DT
core_NN
elements_NNS
of_IN
the_DT
SL3_NN
virus_NN
are_VBP
important_JJ
genetic_JJ
determinants_NNS
of_IN
the_DT
ability_NN
of_IN
this_DT
virus_NN
to_TO
induce_VB
T-cell_NN
lymphomas_NNS
and_CC
the_DT
transcriptional_JJ
activity_NN
of_IN
the_DT
viral_JJ
long_JJ
terminal_JJ
repeat_NN
in_IN
T_NN
lymphocytes_NNS
._.

CBF_NN
consists_VBZ
of_IN
two_CD
subunits_NNS
,_,
a_DT
DNA_NN
binding_NN
subunit_NN
,_,
CBF_NN
alpha_NN
,_,
and_CC
a_DT
second_JJ
subunit_NN
,_,
CBF_NN
beta_NN
,_,
that_WDT
stimulates_VBZ
the_DT
DNA_NN
binding_NN
activity_NN
of_IN
CBF_NN
alpha_NN
._.

One_CD
of_IN
the_DT
genes_NNS
that_WDT
encodes_VBZ
a_DT
CBF_NN
alpha_NN
subunit_NN
is_VBZ
AML1_NN
,_,
also_RB
called_VBN
Cbf_NN
alpha_NN
2_CD
._.

This_DT
locus_NN
is_VBZ
rearranged_VBN
by_IN
chromosomal_JJ
translocations_NNS
in_IN
human_JJ
myeloproliferative_JJ
disorders_NNS
and_CC
leukemias_NNS
._.

An_DT
exogenously_RB
expressed_VBN
Cbf_NN
alpha_NN
2-encoded_JJ
subunit_NN
-LRB-_-LRB-
CBF_NN
alpha_NN
2-451_CD
-RRB-_-RRB-
stimulated_VBD
transcription_NN
from_IN
the_DT
SL3_NN
enhancer_NN
in_IN
P19_NN
and_CC
HeLa_NN
cells_NNS
._.

Activity_NN
was_VBD
mediated_VBN
through_IN
the_DT
core_NN
elements_NNS
._.

Three_CD
different_JJ
isoforms_NNS
of_IN
CBF_NN
beta_NN
were_VBD
also_RB
tested_VBN
for_IN
transcriptional_JJ
activity_NN
on_IN
the_DT
SL3_NN
enhancer_NN
._.

The_DT
longest_JJS
form_NN
,_,
CBF_NN
beta-187_NN
,_,
increased_VBD
the_DT
transcriptional_JJ
stimulation_NN
by_IN
CBF_NN
alpha_NN
2-451_CD
twofold_JJ
in_IN
HeLa_NN
cells_NNS
,_,
although_IN
it_PRP
had_VBD
no_DT
effect_NN
in_IN
P19_NN
cells_NNS
._.

Transcriptional_JJ
activation_NN
by_IN
CBF_NN
beta_NN
required_VBD
binding_NN
to_TO
the_DT
CBF_NN
alpha_NN
subunit_NN
,_,
as_IN
a_DT
form_NN
of_IN
CBF_NN
beta_NN
that_WDT
lacked_VBD
binding_NN
ability_NN
,_,
CBF_NN
beta-148_NN
,_,
failed_VBD
to_TO
increase_VB
activity_NN
._.

These_DT
results_NNS
indicated_VBD
that_IN
at_IN
least_JJS
in_IN
certain_JJ
cell_NN
types_NNS
,_,
the_DT
maximum_JJ
activity_NN
of_IN
CBF_NN
required_VBD
both_DT
subunits_NNS
._.

They_PRP
also_RB
provided_VBD
support_NN
for_IN
the_DT
hypothesis_NN
that_IN
CBF_NN
is_VBZ
a_DT
factor_NN
in_IN
T_NN
lymphocytes_NNS
that_WDT
is_VBZ
responsible_JJ
for_IN
recognition_NN
of_IN
the_DT
SL3_NN
cores_NNS
._.

We_PRP
also_RB
examined_VBD
whether_IN
CBF_NN
could_MD
distinguish_VB
a_DT
1-bp_JJ
difference_NN
between_IN
the_DT
enhancer_NN
core_NN
of_IN
SL3_NN
and_CC
the_DT
core_NN
of_IN
the_DT
nonleukemogenic_JJ
virus_NN
,_,
Akv_NN
._.

This_DT
difference_NN
strongly_RB
affects_VBZ
transcription_NN
in_IN
T_NN
cells_NNS
and_CC
leukemogenicity_NN
of_IN
SL3_NN
._.

However_RB
,_,
no_DT
combination_NN
of_IN
CBF_NN
alpha_NN
and_CC
CBF_NN
beta_NN
subunits_NNS
that_IN
we_PRP
tested_VBD
was_VBD
able_JJ
to_TO
distinguish_VB
the_DT
1-bp_JJ
difference_NN
in_IN
transcription_NN
assays_NNS
._.

Thus_RB
,_,
a_DT
complete_JJ
understanding_NN
of_IN
how_WRB
T_NN
cells_NNS
recognize_VBP
the_DT
SL3_NN
core_NN
remains_VBZ
to_TO
be_VB
elucidated_VBN
._.

